within Pharmacolibrary.Drugs.M_MusculoSkeletalSystem.M05B_DrugsAffectingBoneStructureAndMineralization.M05BB07_RisedronicAcidAndColecalciferol;
model RisedronicAcidAndColecalciferol 
   extends Pharmacolibrary.Drugs.ATC.M.M05BB07;

  annotation(Documentation(
    info ="<html><body><p>Combination product of risedronic acid (a bisphosphonate for osteoporosis and bone diseases) and colecalciferol (vitamin D3, used to enhance calcium absorption and bone health). This fixed-dose combination is approved in some countries for prevention and treatment of osteoporosis in patients at risk of vitamin D deficiency.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters for the fixed combination in adults; estimates based on individual components due to lack of direct published population PK data on the combination.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end RisedronicAcidAndColecalciferol;
